Joseph Tandurella

8PUBLICATIONS
94CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 05, 2026
Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancreatic Cancer.

|Jan 12, 2026
Cytometric Atlas of Combination Immunotherapy in Pancreatic Cancer: Blood-Based Signatures Reveal Vaccine and Checkpoint Inhibitor Responses.

Dimitrios N Sidiropoulos, Zhehao Zhang, Jennifer N Durham

|Jan 12, 2026
A Randomized Phase II Study: CRS207/GVAX plus Anti-PD-1 and Anti-CTLA4 Recruits Mesothelin- and mKRAS-Specific T Cells into PDAC.

Katherine M Bever, Amanda L Huff, Ludmila Danilova

|Sep 24, 2025
Spatial profiling of human pancreatic ductal adenocarcinoma reveals molecular alterations associated with venous invasion.

Alexander T F Bell, Peter Chianchiano, Katsuya Hirose

|Nov 12, 2024
Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trial.

Marina Baretti, Ludmila Danilova, Jennifer N Durham

|Apr 08, 2024
Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal Adenocarcinoma.

Samantha Guinn, Benedict Kinny-Köster, Joseph A Tandurella

Pageof 2

Frequent Collaborators

8 joint publications

Elana J Fertig

6 joint publications

Ludmila Danilova

6 joint publications

Elizabeth M Jaffee

5 joint publications

Won Jin Ho